{
  "id": 4653743,
  "title": "Eli Lilly is down 11% from all-time highs; should investors load up?",
  "url": "https://urgent.news/2026/08/31/eli-lilly-is-down-11-from-all-time-highs-should-investors-load-up",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-31T14:18:08.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/eli-lilly-is-down-11-from-alltime-highs-should-investors-load-up-93CH-4882975"
  },
  "original_language": "en",
  "account": "Eli Lilly experienced a ~10.5% decline from its 52-week high of $1,292.65, trading at $1,157.27 as of August 31, 2026. Despite the short-term technical signals warning, the company's fundamentals remain strong. Over the past five years, revenue has more than doubled from $28.3B to $65.2B and gross margins expanded from 75.4% to 83.0%. The earnings per share (EPS) grew nearly fourfold from $6.12 to $22.95, and the return on equity (ROE) is an exceptional 102.4%. These metrics indicate Eli Lilly's efficiency and profitability, which are rare for a company with a market capitalization of $1.05T.\n\nThe recent dip may be attributed to profit-taking and broad market pressure rather than a fundamental issue. The Fair Value model suggests a modest upside of +7.0% from the current price of $1,157.27, indicating that the market has already priced in significant growth. Analysts' consensus target is even more optimistic at +17.1%, although they have tended to underestimate Lilly's execution potential in the past.\n\nFor investors, the key question is whether the current entry level offers sufficient safety margin amidst the $1.05T market cap and premium valuation. If the price holds just above the first support zone (S1) at $1,136.79, it may present a more attractive risk/reward scenario. Existing holders may view the pullback as noise within a broader trend, while new investors should wait for stabilizing signals before committing fully.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}